Guardian Pharmacy Services (GRDN) Stock Analysis & Winston Score
Guardian Pharmacy Services delivers prescription medications and pharmacy services to people living in long-term care facilities, such as nursing homes and assisted living communities. Instead of patients going to a regular pharmacy, Guardian brings the medications directly to these facilities and manages the entire dispensing process. The company operates as a specialty pharmacy focused almost entirely on the long-term care market across the United States. Guardian makes money by dispensing medications and charging for the pharmacy management services it provides to care facilities. It operates a network of local pharmacy locations spread across multiple states, allowing it to serve facilities with fast, reliable delivery — a key advantage that is hard for large national chains to replicate at the local level. The main growth driver is the aging U.S. population, which is steadily increasing demand for long-term care beds and the pharmacy services that support them, though reimbursement rate pressure from Medicare and Medicaid remains an ongoing risk to profit margins.
Winston Score: 52/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Weak (6/30)
- Growth: Good (11/20)
- Cash Flow: Strong (7/10)
- Stability: Exceptional (10/10)
- Valuation: Good (5/10)
- Ownership: Good (10/15)
Key Facts
Price: $40.52
Market Cap: $2.6B
Sector: Healthcare
Industry: Medical - Distribution


